Yucca Health review

The offer here is unusual enough to read closely rather than dismiss as marketing. A rate held for as long as you stay on it is a genuine thing to want in this category, where prices have moved a good deal and where most sellers reserve the right to change a figure at any renewal. The promise is on the front of the site and the coupon applies automatically rather than making a reader hunt for a code. The condition attached is a six-month plan, and it is printed in the smallest type on the page, directly under the largest. Six months is a meaningful commitment for someone whose plan is to try a small dose and find out how their body responds, and the honest way to read the offer is as a trade: a lower long-run price in exchange for deciding now. What a reader cannot do here is compare the two molecules. The dual agonist is named on the product itself, described by its mechanism, and given no price anywhere, so someone who suspects it suits them better has nothing to weigh against the figure they can see. No milligram sits behind that figure either, so the lifetime lock is a lock on a number whose contents are unstated — if the amount of drug the plan supplies changes as you titrate, nothing published says whether the locked price follows.

Vs median

$50/mo below the $175 median across the 299 of 548 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Standard plan, self-directed low dose

Consult

Included in the price

Dietitian

Not confirmed

Labs

Not required

Pricing

Check plan terms

Yucca Health does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

The offer here is unusual enough to be worth reading closely rather than dismissing as marketing. A rate held for as long as you stay on it is a genuine thing to want in this category, where prices have moved a good deal and where most sellers reserve the right to change a figure at any renewal. Yucca puts that promise on the front of the site and applies the coupon automatically rather than making a reader hunt for a code. The condition attached is a six-month plan, and it is printed in the smallest type on the page, directly under the largest. Six months is a meaningful commitment for someone whose plan is to try a small dose and find out how their body responds, and the honest way to read the offer is as a trade: a lower long-run price in exchange for deciding now. What a reader cannot do here is compare the two molecules. Tirzepatide is named on the product itself, described by its dual mechanism, and given no price anywhere, so a reader who suspects the dual agonist suits them better has nothing to weigh against the semaglutide figure. No milligram sits behind that figure either, so the lifetime lock is a lock on a number whose contents are unstated — if the amount of drug the plan supplies changes as you titrate, the page does not say whether the locked price follows.

The lock is conditional on a six-month plan, set in the smallest type on the page.

• Tirzepatide is offered and carries no published figure, so the two cannot be compared.
• No dose sits behind the figure, so what the locked price supplies is unstated.

Yucca Health is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What microdosing GLP-1 costs
• Microdosing semaglutide
• Low dose vs full dose
• The true annual cost of a plan